These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 14717914)

  • 1. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
    Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
    Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro.
    Cerini C; Dou L; Anfosso F; Sabatier F; Moal V; Glorieux G; De Smet R; Vanholder R; Dignat-George F; Sampol J; Berland Y; Brunet P
    Thromb Haemost; 2004 Jul; 92(1):140-50. PubMed ID: 15213855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
    Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uremic retention solute p-cresyl sulfate and markers of endothelial damage.
    Meijers BK; Van Kerckhoven S; Verbeke K; Dehaen W; Vanrenterghem Y; Hoylaerts MF; Evenepoel P
    Am J Kidney Dis; 2009 Nov; 54(5):891-901. PubMed ID: 19615803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines.
    Dou L; Cerini C; Brunet P; Guilianelli C; Moal V; Grau G; De Smet R; Vanholder R; Sampol J; Berland Y
    Kidney Int; 2002 Dec; 62(6):1999-2009. PubMed ID: 12427124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells.
    Dou L; Jourde-Chiche N; Faure V; Cerini C; Berland Y; Dignat-George F; Brunet P
    J Thromb Haemost; 2007 Jun; 5(6):1302-8. PubMed ID: 17403109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A uremic solute, P-cresol, inhibits the proliferation of endothelial progenitor cells via the p38 pathway.
    Ying Y; Yang K; Liu Y; Chen QJ; Shen WF; Lu L; Zhang RY
    Circ J; 2011; 75(9):2252-9. PubMed ID: 21747198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does uremia cause vascular dysfunction?
    Brunet P; Gondouin B; Duval-Sabatier A; Dou L; Cerini C; Dignat-George F; Jourde-Chiche N; Argiles A; Burtey S
    Kidney Blood Press Res; 2011; 34(4):284-90. PubMed ID: 21691132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro.
    Idziak M; Pędzisz P; Burdzińska A; Gala K; Pączek L
    Exp Toxicol Pathol; 2014 Jul; 66(4):187-94. PubMed ID: 24548687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro.
    Faure V; Cerini C; Paul P; Berland Y; Dignat-George F; Brunet P
    Int Immunol; 2006 Oct; 18(10):1453-9. PubMed ID: 16954166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of circulating endothelial microparticles in patients with chronic renal failure.
    Faure V; Dou L; Sabatier F; Cerini C; Sampol J; Berland Y; Brunet P; Dignat-George F
    J Thromb Haemost; 2006 Mar; 4(3):566-73. PubMed ID: 16405517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-bound uremic retention solutes.
    Brunet P; Dou L; Cerini C; Berland Y
    Adv Ren Replace Ther; 2003 Oct; 10(4):310-20. PubMed ID: 14681860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
    Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
    Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
    Shafi T; Sirich TL; Meyer TW; Hostetter TH; Plummer NS; Hwang S; Melamed ML; Banerjee T; Coresh J; Powe NR
    Kidney Int; 2017 Dec; 92(6):1484-1492. PubMed ID: 28739139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.